natgillin/translations-raw huggingface dataset:
Submission and evaluation of pesticide residues data for the estimation of Maximum Residue Levels in food and feed.
Dostava i ocjena podataka o ostacima pesticida za određivanje maksimalnih razina ostataka u hrani i hrani za životinje.
Commission Implementing Regulation (EU) 2017/694
Provedbena uredba Komisije (EU) 2017/694
of 12 April 2017
оd 12. travnja 2017.
Done at Brussels, 12 April 2017.
Sastavljeno u Bruxellesu 12. travnja 2017.
Commission Delegated Regulation (EU) 2017/698
Delegirana uredba Komisije (EU) 2017/698
amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products
o izmjeni Delegirane uredbe (EU) br. 1062/2014 o programu rada za sustavni pregled svih postojećih aktivnih tvari sadržanih u biocidnim proizvodima iz Uredbe (EU) br. 528/2012 Europskog parlamenta i Vijeća o stavljanju na raspolaganje na tržištu i uporabi biocidnih proizvoda
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [1] and in particular Article 89(1) thereof,
uzimajući u obzir Uredbu (EU) br. 528/2012 Europskog parlamenta i Vijeća od 22. svibnja 2012. o stavljanju na raspolaganje na tržištu i uporabi biocidnih proizvoda [1], a posebno njezin članak 89. stavak 1.
Commission Delegated Regulation (EU) No 1062/2014 [2] sets out, in its Annex II, an exhaustive list of existing active substances/product-type combinations included in the programme of review of existing biocidal active substances on 4 August 2014.
U Prilogu II. Delegiranoj uredbi Komisije (EU) br. 1062/2014 [2] utvrđuje se konačan popis postojećih kombinacija aktivnih tvari/vrste proizvoda uključene u program pregleda postojećih biocidnih aktivnih tvari na dan 4. kolovoza 2014.
According to Article 14(3) of Delegated Regulation (EU) No 1062/2014, any person could have notified a substance/product-type combination included in part 2 of Annex II thereto within 12 months from the entry into force of that Regulation.
U skladu s člankom 14. stavkom 3. Delegirane uredbe (EU) br. 1062/2014 sve su osobe mogle u roku od 12 mjeseci od stupanja na snagu te uredbe prijaviti kombinaciju tvari/vrste proizvoda uvrštenu u dio 2. Priloga II.
Since that deadline has passed, part 2 of Annex II and Article 14(3) of that Regulation have become obsolete and Commission Implementing Decision (EU) 2016/1950 [3] has been taken not approving these substance/product type combinations.
Nakon isteka tog roka dio 2. Priloga II. i članak 14. stavak 3. te uredbe zastarjeli su te je donesena Provedbena odluka Komisije (EU) 2016/1950 [3] o neodobravanju tih kombinacija tvari/vrste proizvoda.
Substance/product-type combinations notified pursuant to Article 14(3) and found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014 should be included in part 1 of Annex II to that Regulation and removed from part 2 of that Annex.
Kombinacije tvari/vrste proizvoda koje su prijavljene na temelju članka 14. stavka 3., a koje su u skladu s člankom 17. stavkom 2. Delegirane uredbe (EU) br. 1062/2014 trebalo bi uvrstiti u dio 1. Priloga II. toj uredbi i izbrisati iz dijela 2. tog priloga.
According to Article 16(4) of Delegated Regulation (EU) No 1062/2014, an invitation was published where any person with an interest could notify the relevant active substance/product-type combination(s).
U skladu s člankom 16. stavkom 4. Delegirane uredbe (EU) br. 1062/2014 objavljen je poziv na temelju kojeg sve osobe mogu prijaviti interes za odgovarajuće kombinacije aktivne tvari/vrste proizvoda.
One notification pursuant to Article 16(5) of Delegated Regulation (EU) No 1062/2014 and concerning dialuminium chloride pentahydroxide for use in product-type 2, was made before the deadline and was found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014.
Jedna je prijava na temelju članka 16. stavka 5. Delegirane uredbe (EU) br. 1062/2014 u pogledu uporabe dialuminijeva klorid pentahidroksida u proizvodima vrste 2 podnesena prije roka, a utvrđeno je da je u skladu s člankom 17. stavkom 2. Delegirane uredbe (EU) br. 1062/2014.
Therefore this substance/product-type combination has to be included in part 1 of Annex II to that Regulation.
Stoga je tu kombinaciju tvari/vrste proizvoda potrebno uvrstiti u dio 1. Priloga II. toj uredbi.
The Evaluating Competent Authority should be appointed pursuant to Article 81 of Regulation (EU) No 528/2012 for the active substance/product-type combinations mentioned in recital 3 and 4.
Na temelju članka 81. Uredbe (EU) br. 528/2012 trebalo bi imenovati nadležno ocjenjivačko tijelo za kombinacije aktivne tvari/vrste proizvoda iz uvodnih izjava 3. i 4.
Active substance/product-type combinations for which a decision of approval or non-approval has been adopted since 4 August 2014 are no longer in the review programme, and therefore shall no longer be referred to in part 1 of Annex II to Delegated Regulation (EU) No 1062/2014.
Kombinacije aktivne tvari/vrste proizvoda za koje je odluka o odobrenju ili neodobrenju donesena nakon 4. kolovoza 2014. više nisu u programu pregleda i stoga se na njih više ne upućuje u dijelu 1. Priloga II. Delegiranoj uredbi (EU) br. 1062/2014.
The substance/product-type combinations listed in part 2 of Annex II to Delegated Regulation (EU) No 1062/2014 that were not notified pursuant to Article 14(3) of the Review Regulation should be removed from part 2 of that Annex.
Kombinacije tvari/vrste proizvoda navedene u dijelu 2. Priloga II. Delegiranoj uredbi (EU) br. 1062/2014 koje nisu prijavljene na temelju članka 14. stavka 3. Uredbe o pregledima trebalo bi izbrisati iz dijela 2. tog priloga.
Part 2 of that Annex therefore becomes obsolete and should be removed.
Dio 2. tog priloga stoga je zastario i trebalo bi ga izbrisati.
Consequently, part 1 of Annex II to Delegated Regulation (EU) No 1062/2014 should become Annex II as it is the only remaining part in Annex II and references to Article 14(3) and part 1 of Annex II need to be removed.
Zbog toga bi dio 1. Priloga II. Delegiranoj uredbi (EU) br. 1062/2014 trebao postati Prilog II. s obzirom na to da je jedini preostali dio u Prilogu II., a upućivanja na članak 14. stavak 3. i dio 1. Priloga II. potrebno je izbrisati.
Delegated Regulation (EU) No 1062/2014 should therefore be amended accordingly,
Delegiranu uredbu (EU) br. 1062/2014 trebalo bi stoga na odgovarajući način izmijeniti,
Delegated Regulation (EU) No 1062/2014 is amended as follows:
Delegirana uredba (EU) br. 1062/2014 mijenja se kako slijedi:
In Article 14, paragraph 3 is deleted.
U članku 14., stavak 3. briše se.
Notifications pursuant to Article 14(2) or Article 16(5) shall be made to the Agency through the Register.’
Prijave na temelju članka 14. stavka 2. ili članka 16. stavka 5. podnose se Agenciji putem registra.”
in paragraph 7, point (a) is replaced by the following:
u stavku 7., točka (a) zamjenjuje se sljedećim:
where the notification has been submitted pursuant to Article 14(2), update the information in the Register with respect to the identity of the participant and, where relevant, of the substance;’.
kada je prijava podnesena u skladu s člankom14. stavkom 2. ažurira podatke u registru u odnosu na identitet sudionika i, kad je to primjereno, identitet tvari;”
In Article 20 points (b) and (c) are replaced by the following:
U članku 20., točke (b) i (c) zamjenjuju se sljedećim:
where no person has submitted a notification within the time limits provided for by Article 14(2) of this Regulation, or where such a notification has been submitted and rejected pursuant to Article 17(4) or Article 17(5) thereof;
kada nitko ne podnese prijavu u rokovima predviđenima člankom 14. stavkom 2. ove Uredbe ili ako je ta prijava primljena i odbijena u skladu s člankom 17. stavcima 4. ili 5.;
where a notification has been submitted within the time limits provided for by Article 14(2) of this Regulation and has been found compliant pursuant to Article 17(5) thereof, but the substance identity in the notification only covers part of the existing identity in Annex II to this Regulation.’.
kada je prijava podnesena u rokovima predviđenima člankom 14. stavkom 2. ove Uredbe i utvrđeno je da ispunjava zahtjeve u skladu s člankom 17. stavkom 5., ali identitet tvari iz prijave obuhvaća samo dio postojećeg identiteta iz Priloga II. ovoj Uredbi.”
Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 (OJ L 294, 10.10.2014, p. 1).
Delegirana uredba Komisije (EU) br. 1062/2014 оd 4. kolovoza 2014. o programu rada za sustavni pregled svih postojećih aktivnih tvari sadržanih u biocidnim proizvodima iz Uredbe (EU) br. 528/2012 (SL L 294, 10.10.2014., str. 1.).
Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 300, 8.11.2016, p. 14).
Provedbena odluka Komisije (EU) 2016/1950 оd 4. studenoga 2016. o neodobravanju određenih biocidnih aktivnih tvari na temelju Uredbe (EU) br. 528/2012 Europskog parlamenta i Vijeća (SL L 300, 8.11.2016., str. 14.).
SUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 3 FEBRUARY 2017
KOMBINACIJE TVARI/VRSTE PROIZVODA KOJE SU UKLJUČENE U PROGRAM PREGLEDA NA DAN 3. VELJAČE 2017.
Active substance/product-type combinations supported on 3 February 2017 excluding any other nanomaterial than those explicitly mentioned in entries 1017, 1019 and 1023
Kombinacije aktivne tvari/vrste proizvoda s podrškom na dan 3. veljače 2017., isključujući sve druge nanomaterijale osim onih izričito navedenih u unosima 1017, 1019 i 1023
Entry number
Broj unosa
Substance name
Naziv tvari
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (Piperonyl butoxide/PBO)
2-(2-butoksietoksi)etil 6-propilpiperonil eter (piperonil butoksid/PBO)
Glycolic acid
glikolna kiselina
L-(+)-lactic acid
L-(+)-mliječna kiselina
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone)
(2R,6aS,12aS)-1,2,6,6a,12,12a-heksahidro-2-izopropenil-8,9-dimetoksikromeno[3,4-b]furo[2,3-h]kromen-6-on (rotenon)
Symclosene
simklozen
Biphenyl-2-ol
bifenil-2-ol
Cinnamaldehyde/3-phenyl-propen-2-al (Cinnamic aldehyde)
cinamaldehid/3-fenil-propen-2-al (cimetni aldehid)
Glyoxal
glioksal
Hexa-2,4-dienoic acid (Sorbic acid)
heksa-2,4-dienoična kiselina (sorbinska kiselina)
Clorophene (Chlorophene)
klorofen
Cetylpyridinium chloride
cetilpiridinijev klorid
Sodium dimethylarsinate (Sodium Cacodylate)
natrijev dimetilarsinat (natrijev kakodilat)
Tosylchloramide sodium (Tosylchloramide sodium — Chloramin T)
natrijev tosilkloramid (natrijev tosilkloramid – kloramin T)
Potassium dimethyldithiocarbamate
kalijev dimetilditiokarbamat
Sodium dimethyldithiocarbamate
natrijev dimetilditiokarbamat
Sodium 2-biphenylate
natrijev 2-bifenilat
Thiram
tiram
Metam-sodium
metam-natrij
hiazol-4-yl-1H-benzoimidazole (Thiabendazole)
iazol-4-il-1H-benzoimidazol (tiabendazol)
Cyanamide
cianamid
Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet)
tetrahidro-3,5-dimetil-1,3,5-tiadiazin-2-tion (dazomet)
Terbutryn
terbutrin
N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid)
N-(diklorofluorometiltio)-N′,N′-dimetil-N-fenilsulfamid (diklofluanid)
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin)
(1,3,4,5,6,7-heksahidro-1,3-diokso-2H-izoindol-2-il)metil (1R-trans)-2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (d-tetrametrin)
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine)
N-(3-aminopropil)-N-dodecilpropan-1,3-diamin (diamin)
2,2′-dithiobis[N-methylbenzamide] (DTBMA)
2,2′-ditiobis[N-metilbenzamid] (DTBMA)
1,2-benzisothiazol-3(2H)-one (BIT)
1,2-benzizotiazol-3(2H)-on (BIT)
ethyl-2H-isothiazol-3-one (MIT)
etil-2H-izotiazol-3-on (MIT)
Sodium dichloroisocyanurate dihydrate
natrijev dikloroizocianurat dihidrat
Troclosene sodium
troklozen natrij
Mecetronium ethyl sulphate (MES)
mecetronijev etil sulfat (MES)
(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm))
(etilendioksi)dimetanol (produkti reakcije etilen glikola s paraformaldehidom (EGForm))
Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)
piridin-2-tiol 1-oksid, natrijeva sol (pirition natrij)
Methenamine 3-chloroallylochloride (CTAC)
metenamin 3-kloroaliloklorid (CTAC)
2,2′,2′-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT)
2,2′,2′-(heksahidro-1,3,5-triazin-1,3,5-triil)trietanol (HHT)
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD)
tetrahidro-1,3,4,6-tetrakis(hidroksimetil)imidazo[4,5-d]imidazol-2,5(1H,3H)-dion (TMAD)
Methylene dithiocyanate
metilen ditiocianat
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH)
1,3-bis(hidroksimetil)-5,5-dimetilimidazolidin-2,4-dion (DMDMH)
Didecyldimethylammonium chloride (DDAC)
didecildimetilamonijev klorid (DDAC)
Silver, as a nanomaterial
srebro, kao nanomaterijal
Sodium bromide
natrijev bromid
Sodium hypochlorite
natrijev hipoklorit
Tetramethrin
tetrametrin
Hydrogen peroxide
vodikov peroksid
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO)
7a-etildihidro-1H,3H,5H-oksazolo[3,4-c]oksazol (EDHO)
Silver nitrate
srebrov nitrat
Disodium peroxodisulphate/Sodium persulphate
dinatrijev peroksodisulfat/natrijev persulfat
Calcium hypochlorite
kalcijev hipoklorit
Silver chloride
srebrov klorid
Pyrethrins and Pyrethroids
piretrini i piretroidi
Chlorine dioxide
klorov dioksid
2,2-dibromo-2-cyanoacetamide (DBNPA)
2,2-dibromo-2-cianoacetamid (DBNPA)
Carbendazim
karbendazim
Dialuminium chloride pentahydroxide
dialuminijev klorid pentahidroksid
Ammonium bromide
amonijev bromid
Pyrithione zinc (Zinc pyrithione)
pirition cink (cinkov pirition)
Dodecylguanidine monohydrochloride
dodecilgvanidin monohidroklorid
Potassium 2-biphenylate
kalijev 2-bifenilat
Bromine chloride
bromov klorid
(benzyloxy)methanol
(benziloksi)metanol
Sodium p-chloro-m-cresolate
natrijev p-kloro-m-krezolat
D-gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG)
D-glukonska kiselina, spoj s N,N′-bis(4-klorofenil)-3,12-diimino-2,4,11,13-tetraazatetradekandiamidinom (2:1) (CHDG)
p-[(diiodomethyl)sulphonyl]toluene
p-[(dijodometil)sulfonil]toluen
(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB)
(benzotiazol-2-iltio)metil tiocianat (TCMTB)
ethyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin)
etil-4-okso-3-(prop-2-inil)ciklopent- 2-en-1-il 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (praletrin)
Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate)
kalijev (E, E)-heksa-2,4-dienoat (kalijev sorbat)
alpha.,.alpha.′,.alpha.′-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT)
alpha.,.alpha.′,.alpha.′-trimetil-1,3,5-triazin-1,3,5 (2H,4H,6H)-trietanol (HPT)
ctyl-2H-isothiazol-3-one (OIT)
ktil-2H-izotiazol-3-on (ILO)
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
dimetiloktadecil[3-(trimetoksisilil)propil] amonijev klorid
Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH/Bromochlorodimethylhydantoin)
bromokloro-5,5-dimetilimidazolidin-2,4-dion (BCDMH/bromoklorodimetilhidantoin)
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
3-(4-izopropilfenil)-1,1-dimetilurea/izoproturon
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)
1-[2-(aliloksi)-2-(2,4-diklorofenil)etil]-1H-imidazol (imazalil)
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos)
S-[(6-kloro-2-oksooksazolo[4,5-b]piridin-3(2H)-il)metil] O,O-dimetil tiofosfat (azametifos)
alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin)
alfa.-ciano-3-fenoksibenzil 2,2-dimetil- 3-(2-metilprop-1-enil)ciklopropankarboksilat (cifenotrin)
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride
dimetiltetradecil[3-(trimetoksisilil)propil]amonijev klorid
Mixture of cis- and trans-p-menthane-3,8 diol (Citriodiol)
smjesa cis- i trans-p-mentan-3,8 diola (citriodiol)
(RS)-α-cyano-3phenoxybenzyl-(1RS)- cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin)
(RS)-α-cijano-3fenoksibenzil-(1RS)-cis,trans-3-(2,2-diklorovinil)-2,2-dimetilciklopropankarboksilat (cipermetrin)
thynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin)
tinil-2-metilpent-2-enil 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (empentrin)
odo-2-propynylbutylcarbamate (IPBC)
odo-2-propinilbutilkarbamat (IPBC)
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)
tetrakis(hidroksimetil)fosfonij sulfat (2:1) (THPS)
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro- 2-octyl-2H- isothiazol-3-one (DCOIT))
4,5-dikloro-2-oktilizotiazol-3(2H)-on (4,5-dikloro- 2-oktil-2H- izotiazol-3-on (DCOIT))
3,3′-methylenebis[5-methyloxazolidine] (Oxazolidin/MBO)
3,3′-metilenbis[5-metiloksazolidin] (oksazolidin/MBO)
Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18))
alkil (C12-18) dimetilbenzil amonijev klorid (ADBAC (C12-18))
Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16))
alkil (C12-16) dimetilbenzil amonijev klorid (ADBAC/BKC (C12-C16))
Didecyldimethylammonium chloride (DDAC (C8-10))
didecildimetilamonijev klorid (DDAC, (C8-10))
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS)
kvaterni amonijevi spojevi, benzil-C12-18-alkildimetil, soli s 1,2-benzizotiazol-3(2H)-on 1,1-dioksidom (1:1) (ADBAS)
Sodium N-(hydroxymethyl)glycinate
natrijev N-(hidroksimetil)glicinat
Amines, C10-16-alkyldimethyl, N-oxides
amini, C10-16-alkildimetil, N-oksidi
Pentapotassium bis(peroxymonosulphate) bis(sulphate)
pentakalijev bis(peroksimonosulfat) bis(sulfat)
Magnesium monoperoxyphthalate hexahydrate (MMPP)
magnezijev monoperoksiftalat heksahidrat (MMPP)
Margosa extract
ekstrakt margosa
Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxide
Ekstrakt margosa od hladnoprešana ulja koštica Azadirchta indica ekstrahiranog superkritičnim ugljikovim dioksidom
Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14))
alkil (C12-C14) dimetilbenzilamonijev klorid (ADBAC (C12-C14))
Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14))
alkil (C12-C14) dimetil(etilbenzil)amonijev klorid (ADEBAC (C12-C14))
Lavender, Lavandula hybrida, ext./Lavandin oil
lavanda, Lavandula hybrida, ekstrakt/ulje lavandina
Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)
produkti reakcije glutaminske kiseline i N-(C12-C14-alkil)propilenediamina (glukoprotamin)
6-(phthalimido)peroxyhexanoic acid (PAP)
6-(ftalimido)peroksiheksanska kiselina (PAP)
utyl-benzo[d]isothiazol-3-one (BBIT)
util-benzo[d]izotiazol-3-on (BBIT)
Tetrachlorodecaoxide complex (TCDO)
tetraklorodekaoksid kompleks (TCDO)
Silver sodium hydrogen zirconium phosphate
srebro natrij hidrogen cirkonij fosfat
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine (Icaridine)
sek-butil 2-(2-hidroksietil)piperidin-1- karboksilat/ikaridin (ikaridin)
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC)
cis-1-(3-kloroalil)-3,5,7-triaza-1- zoniaadamantan klorid (ccis CTAC)
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate (Imiprothrin)
[2,4-diokso-(2-propin-1-il)imidazolidin-3-il]metil(1R)-cis-krizantemat; [2,4-diokso-(2-propin-1-il)imidazolidin-3-il]metil(1R)-trans-krizantemat (imiprotrin)
1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin)
1-(2-kloro-1,3-tiazol-5-ilmetil)-3-metil-2-nitrogvanidin (klotianidin)
Bacillus sphaericus other than Bacillus sphaericus 2362, strain ABTS-1743
Bacillus sphaericus, osim Bacillus sphaericus 2362, soj ABTS-1743
Micro-organism
mikroorganizam
Bacillus thuringiensis subsp.israelensis Serotype H14, other than strain AM65-52 and other than strain SA3A
Bacillus thuringiensis subsp.israelensis serotip H14, osim soja AM65-52 i osim soja SA3 A
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ
aktivni klor: dobiven reakcijom hipoklorne kiseline i natrij hipoklorita, proizveden in situ
Mixture
smjesa
Peroxyoctanoic acid
peroksioktanska kiselina
Silver zeolite
srebrni zeolit
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH)
produkti reakcije 5,5-dimetilhidantoina, 5-etil-5-metilhidantoina s bromom i klorom (DCDMH)
Not available
nije dostupno
Reaction mass of titanium dioxide and silver chloride
masa reakcije titanova dioksida i srebrova klorida
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH)
produkti reakcije 5,5-dimetilhidantoina, 5-etil-5-metilhidantoina s klorom (DCEMH)
Silver phosphate glass
srebro-fosfatno staklo
Silver zinc zeolite
srebro-cink-zeolit
Silver copper zeolite
srebro-bakar-zeolit
Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale)
srebro adsorbirano na silicijev dioksid (kao nanomaterijal u obliku stabilnog agregata s primarnim česticama u nanorazini)
Silicon dioxide (as a nanomaterial formed by aggregates and agglomerates)
silicijev dioksid (kao nanomaterijal koji čine agregati i aglomerati)
Silicium dioxide (Silicium dioxide/Kieselguhr)
silicijev dioksid (silicijev dioksid/dijatomejska zemlja)
Plant protection product
sredstvo za zaštitu bilja
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin)
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R;1R,3S)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (smjesa četiri izomera: 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-aletrin)
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin)
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (smjesa dva izomera: 1R trans: 1R/S samo 1:3) (esbiotrin)
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide (Acetamiprid)
N-((6-kloro-3-piridinil)metil)-N′-ciano-N-metiletanimidamid (acetamiprid)
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate (Esfenvalerate)
esfenvalerat/(S)-.alfa.-ciano-3-fenoksibenzil (S)-2-(4-klorofenil)-3-metilbutirat (esfenvalerat)
romo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr)
romo-2-(4-klorofenil)-1-etoksimetil-5-trifluorometilpirol-3-karbonitril (klorfenapir)
Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer)
polimer N-metilmetanamina (EINECS 204-697-4 s (klorometil)oksiranom (EINECS 203-439-8)/polimerni kvaterni amonijev klorid (PQ polimer)
Polymer
polimer
Monohydro chloride of polymer of N,N″-1,6-hexanediylbis[N′-cyanoguanidine] (Einecs 240-032-4) and hexamethylenediamine (Einecs 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) (PHMB)
monohidroklorid polimera N,N″-1,6-heksandiilbis[N′-cianogvanidina] (EINECS 240-032-4) i heksametilendiamina (EINECS 204-679-6)/poliheksametilen bigvanid (monomer: 1,5-bis(trimetilen)-gvanilgvanidijev monohidroklorid) (PHMB)
Poly(hexamethylenebiguanide)
poli(heksametilenbigvanid)